Home/Filings/4/0001181431-12-026443
4//SEC Filing

ZOLL MEDICAL CORP 4

Accession 0001181431-12-026443

CIK 0000887568operating

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 6:11 PM ET

Size

23.5 KB

Accession

0001181431-12-026443

Insider Transaction Report

Form 4
Period: 2012-04-26
FLORA STEVEN K
Senior VP North American Sales
Transactions
  • Exercise/Conversion

    Stock Option

    2012-04-268,0000 total
    Exercise: $37.67From: 2012-11-15Exp: 2021-11-15Common Stock (8,000 underlying)
  • Exercise/Conversion

    Common Stock

    2012-04-26$30.27/sh+20,000$605,40035,500 total
  • Disposition to Issuer

    Common Stock

    2012-04-26$93.00/sh2,732$254,0760 total
  • Exercise/Conversion

    Stock Option

    2012-04-2611,2500 total
    Exercise: $20.23From: 2010-11-10Exp: 2019-11-10Common Stock (11,250 underlying)
  • Disposition to Issuer

    Common Stock

    2012-04-26$93.00/sh43,500$4,045,5000 total
  • Exercise/Conversion

    Common Stock

    2012-04-26$37.67/sh+8,000$301,36043,500 total
  • Exercise/Conversion

    Common Stock

    2012-04-26$20.23/sh+11,250$227,58815,500 total
  • Exercise/Conversion

    Stock Option

    2012-04-264,2500 total
    Exercise: $22.05From: 2009-11-11Exp: 2018-11-11Common Stock (4,250 underlying)
  • Exercise/Conversion

    Common Stock

    2012-04-26$22.05/sh+4,250$93,7134,250 total
  • Disposition from Tender

    Common Stock

    2012-04-26$93.00/sh8,000$744,0000 total(indirect: See Footnote)
  • Tax Payment

    Common Stock

    2012-04-261,2680 total
  • Exercise/Conversion

    Stock Option

    2012-04-2620,0000 total
    Exercise: $30.27From: 2011-11-16Exp: 2020-11-16Common Stock (20,000 underlying)
Footnotes (4)
  • [F1]The shares are held by the Robert W. Baird & Co. Inc. TTEE FBO Steven K. Flora IRA.
  • [F2]These restricted stock awards vested in full and were cancelled immediately prior to the effective time of the merger (the "Merger") pursuant to that certain Agreement and Plan of Merger, dated March 12, 2012, by and among ZOLL Medical Corporation, Asahi Kasei Corporation, Asahi Kasei Holdings US, Inc. and Asclepius Subsidiary Corporation (the "Merger Agreement") in exchange for an aggregate cash payment equal to the number of shares of ZOLL Medical Corporation's common stock underlying such restricted stock awards multiplied by the per share purchase price of $93.00.
  • [F3]Disposed of at the effective time of the Merger pursuant to the terms of the Merger Agreement.
  • [F4]Represents options under ZOLL Medical Corporation's Amended and Restated 2001 Stock Incentive Plan that were either fully exercisable or accelerated in full and exercised pursuant to the terms of the Merger Agreement.

Issuer

ZOLL MEDICAL CORP

CIK 0000887568

Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000887568

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 6:11 PM ET
Size
23.5 KB